The article examines another way to regulate the neuromuscular junction (NMJ). The transcriptional co-activator peroxisome proliferator-activated receptor co-activator 1α (PGC-1α) is a key regulator of the neuromuscular junction. It is a potential target for Duchenne muscular dystrophy therapy. PGC-1α regulates the expression of a broad profile of genes.